The novel treatment of the medication represents a significant development in the care of the condition. Distinct from existing therapies, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide976176.arwebo.com/64586825/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment